PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
7.23%
Net income growth under 50% of AVGO's 46.71%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
3.49%
Some D&A expansion while AVGO is negative at -0.82%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
675.00%
Well above AVGO's 75.20% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
9.84%
SBC growth well above AVGO's 16.99%. Michael Burry would flag major dilution risk vs. competitor’s approach.
139.52%
Well above AVGO's 206.25% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
109.01%
AR growth well above AVGO's 183.82%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-39.53%
Both reduce yoy inventory, with AVGO at -20.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
61.19%
AP growth well above AVGO's 117.75%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
154.92%
Some yoy usage while AVGO is negative at -298.80%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-320.00%
Both negative yoy, with AVGO at -122.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
62.24%
Operating cash flow growth above 1.5x AVGO's 25.09%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-13.15%
Both yoy lines negative, with AVGO at -26.26%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-60.40%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-87.37%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-1890.91%
We reduce yoy other investing while AVGO is 66966.67%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-121.99%
We reduce yoy invests while AVGO stands at 99.30%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment above 1.5x AVGO's 34.88%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-3.31%
Negative yoy issuance while AVGO is 95.16%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
25.09%
Buyback growth below 50% of AVGO's 62.14%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.